Foresite Capital Management IV as of Sept. 30, 2023
Portfolio Holdings for Foresite Capital Management IV
Foresite Capital Management IV holds 7 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pharvaris N V (PHVS) | 43.4 | $78M | 3.7M | 20.87 | |
| Cymabay Therapeutics | 14.8 | $27M | 1.8M | 14.91 | |
| Aclaris Therapeutics (ACRS) | 10.7 | $19M | 2.8M | 6.85 | |
| Kura Oncology (KURA) | 9.4 | $17M | 1.8M | 9.12 | |
| Kinnate Biopharma | 7.5 | $14M | 9.7M | 1.40 | |
| Lyell Immunopharma (LYEL) | 7.2 | $13M | 8.8M | 1.47 | |
| Syndax Pharmaceuticals (SNDX) | 7.1 | $13M | 875k | 14.52 |
